Hjorth CF, Nielsen AS, Sørensen HT, Lash TL, Damkier P, Hamilton-Dutoit S, et al. Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study. AO [Internet]. 2019 Feb. 1 [cited 2025 Feb. 26];58(2):168-74. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24387